Skip to main content
. 2018 May 8;9(35):23960–23974. doi: 10.18632/oncotarget.25251

Table 2. Univariate Cox regression analysis between genes showing SNVs and patients’ OS or clinical covariates previously selected by Log-Rank test in CC patients.

Covariates OS
HR 95% CI p-value
T (TMN) (1-3/4) 12.33 1.28 - 118.8 0.029*
Stage (I+II+III/IV) 0.1175 0.01 - 0.73 0.0221*
M (TNM) stage (M0/M1) 11.7674 1.83 - 75.52 0.00935*
NBN 14.75 2.03 - 106.8 0.0004*
SMUG1 17.754 2.42 - 129.8 0.0001*
ERBB2 17.158 1.8 - 156.2 0.0007*
PTPRT 11.342 1.57 - 81.77 0.002*
EPHB1 11.005 1.54 - 78.25 0.002*
ALK 7.49 1.05 - 53.21 0.01*
PTPRD 8.0739 1.18 - 54.9 0.019*
AURKB 8.689 1.16 - 64.62 0.02*
KDR 6.897 0.96 - 49.11 0.025*
GPR124 6.853 0.94 - 49.78 0.028*

*p-value ≤ 0.05.